TrialDrug design, development and therapy2018

Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study.

Gisèle Pickering et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.